Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVO.L Regulatory News (DVO)

  • There is currently no data for DVO

Directorate Changes

22 Oct 2020 07:00

RNS Number : 8456C
Devro PLC
22 October 2020
 

22 October 2020

 

DEVRO PLC ("DEVRO" OR THE "COMPANY")

 

Directorate Changes

 

Devro, one of the world's leading manufacturers of collagen products for the food industry, announces the appointment of Chantal Cayuela to the Board as an independent non-executive director of the Company with effect from 1 January 2021. Chantal will also become a member of the Audit Committee, the Executive Remuneration Committee and the Nomination Committee from that date.

Chantal currently leads the R&D and Innovation team for Kellogg's European business, where she has been a Vice President since 2018. In a broad-ranging, international, career working with global food manufacturers, she has helped to shape their commercial strategies through product innovation. Her career includes a period of over sixteen years working in a variety of roles at Danone through which she developed considerable expertise in the successful delivery of customer-focused innovation. She subsequently spent seven years leading the Group Bel's research, innovation and development during which time her leadership of, and approach to, product innovation played a pivotal role in reinvigorating the brand, enabling the business to grow beyond its traditional core cheese markets. Chantal is a French national and she holds a doctorate in Biotechnology Chemical Engineering Sciences.

Devro also announces that Dr Paul Withers, non-executive director, will retire from the Board on 31 December 2020. Consequently, from 1 January 2021, Lesley Jackson will become the Company's Senior Independent Director.

Steve Good, Devro's Chairman, said:

"I am delighted to welcome Chantal to Devro's Board of Directors. She brings extensive experience of successful product innovation in international food manufacturing businesses and will add valuable skills and insights to support the development and execution of the Company's growth strategy.

"On behalf of the Board, I would also like to thank Paul for his invaluable service as a non-executive director since 2011 and, particularly in the last year as the Company's Senior Independent Director, for his flexibility and contribution to the initiative to refresh the composition of the Board, completed with Chantal's appointment. I wish him well for the future."

Nothing in connection with Chantal's appointment falls to be disclosed under LR 9.6.13.

 

ENDS

 

Contacts:

 

Devro plc

Rutger Helbing

Chief Executive Officer

Tel: 020 3865 7637

 

FTI Consulting

Richard Mountain / Nick Hasell

Tel: 020 3727 1340

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPGAAUUPUGMG
Date   Source Headline
28th Feb 202310:37 amGNWForm 8.3 - [Devro plc - 27 02 2023] - (CGWL)
28th Feb 20239:34 amRNSForm 8.3 - Devro Plc
27th Feb 20235:08 pmRNSForm 8.5 (EPT/RI)Devro plc- Amend
27th Feb 20233:30 pmGNWForm 8.3 - Devro plc
27th Feb 20233:20 pmRNSForm 8.3 -Devro plc
27th Feb 202311:42 amRNSForm 8.5 (EPT/RI)-Devro plc
27th Feb 202310:06 amRNSForm 8.3 - DEVRO PLC
27th Feb 20239:39 amRNSForm 8.3 - Devro Plc
27th Feb 20238:12 amRNSForm 8.3 - Devro plc
24th Feb 20233:20 pmRNSForm 8.3 - Devro plc
24th Feb 20231:47 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
24th Feb 20231:45 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
24th Feb 20231:30 pmBUSForm 8.3 - DEVRO PLC
24th Feb 20231:04 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
24th Feb 202311:21 amRNSForm 8.3 - DEVRO PLC
24th Feb 202311:06 amBUSForm 8.3 - Devro plc
24th Feb 202310:56 amRNSForm 8.3 - Devro Plc
24th Feb 202310:48 amRNSForm 8.5 (EPT/RI) - Devro plc
24th Feb 202310:03 amRNSForm 8.5 (EPT/RI) - Devro PLC
24th Feb 20239:33 amRNSForm 8.5 (EPT/RI)-Devro plc Amend
23rd Feb 20233:20 pmRNSForm 8.3 - Devro plc
23rd Feb 20232:47 pmRNSForm 8.3 - Devro plc
23rd Feb 20231:43 pmGNWForm 8.3 - [Devro plc - 22 02 2023] - (CGWL)
23rd Feb 20231:16 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc
23rd Feb 202311:24 amRNSForm 8.3 - Devro Plc
23rd Feb 202311:09 amRNSForm 8.3 - DEVRO PLC
23rd Feb 202311:08 amRNSForm 8.5 (EPT/RI)-Devro plc
23rd Feb 20239:53 amRNSForm 8.5 (EPT/RI) - Devro PLC
23rd Feb 20239:23 amRNSForm 8.3 - Devro plc
23rd Feb 20237:25 amRNSForm 8.3 - DEVRO PLC Amendment
22nd Feb 20234:27 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
22nd Feb 20232:55 pmRNSForm 8.3 - Devro plc
22nd Feb 20231:30 pmBUSForm 8.3 - DEVRO PLC
22nd Feb 20231:24 pmRNSForm 8.3 - DEVRO PLC
22nd Feb 202310:41 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
22nd Feb 202310:39 amRNSForm 8.5 (EPT/NON-RI) - Devro plc
22nd Feb 202310:35 amRNSForm 8.5 (EPT/RI) - Devro plc
22nd Feb 20238:14 amRNSForm 8.3 - Devro Plc
22nd Feb 20237:00 amRNSForm 8.3 - Devro plc
22nd Feb 20237:00 amRNSForm 8.5 (EPT/RI)-Devro plc Amend
22nd Feb 20237:00 amRNSForm 8.5 (EPT/RI)-Devro plc Amend
21st Feb 20236:29 pmRNSForm 8.5 (EPT/RI) - Devro plc Amend
21st Feb 202312:21 pmRNSForm 8.3 - DEVRO PLC
21st Feb 202311:43 amRNSForm 8.3 - Devro plc
21st Feb 202311:30 amRNSForm 8.5 (EPT/RI)-Devro plc
21st Feb 20239:07 amRNSForm 8.3 - Devro plc
21st Feb 20238:44 amRNSForm 8.3 - Devro Plc
20th Feb 20233:20 pmRNSForm 8.3 - Devro plc
20th Feb 20231:30 pmBUSForm 8.3 - DEVRO PLC
20th Feb 202312:40 pmEQSForm 8.3 - The Vanguard Group, Inc.: Devro plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.